Tactile Systems Technology (TCMD) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $0.36
- Estimate
- $0.17
- Surprise
- +111.8%
- Revenue (period 2026-06-30)
- $85.7M
- Score at report (before → after)
- 6.8 → 6.8/10
Revenue source: xbrl.
How the report landed
Tactile Systems Technology (TCMD) beat the $0.17 estimate with diluted EPS of $0.36 — a large 111.8% upside surprise. TrendMatrix's engine moved from Buy (Wait) (6.8/10) to Hold at 6.8/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates TCMD Hold at 6.3/10.
3 of the last 4 quarters beat the estimate; this quarter's +111.8% surprise compares with a +74.4% four-quarter average. Next scheduled report: 2026-11-02.
What supports the rating
- Strong earnings beat streak (3/4)
- Attractive valuation
What argues against it
- Concentration risk — Product: lymphedema products (84.0%)
- Concentration risk — Supplier: single-source component suppliers
- Negative momentum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $23.82
- Price target
- $32.51
- Stop
- $22.31
- Upside to target
- +36.5%
- Reward-to-risk
- 2.9:1
The stock trades at 21.9× trailing but 16.4× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 23 — a level conventionally read as oversold.
Model outputs from TrendMatrix’s engine as of 2026-08-23 — shown for context, not personalized investment advice.
TCMD at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $539.6M
- P/E (fwd)
- 16.4
- P/E (ttm)
- 21.9
- 52-week range
- $12.79–$37.77
- Off 52-week high
- 36.9%
- RSI (14)
- 23
- Volume vs avg
- 0.94×
- Score today
- 6.3/10